Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. optonmda

OptoNMDA

Optical strategies to investigate NMDA receptor functional diversity and its therapeutic potential

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 OptoNMDA project word cloud

Explore the words cloud of the OptoNMDA project. It provides you a very rough idea of what is the project "OptoNMDA" about.

proposes    encoded    deleterious    gated    derivatives    sites    physiology    light    active    transmission    pathology    inactive    signalling    preparations    receptor    glun2b    glun2    plasticity    mental    site    ex    physiological    vivo    subunits    dysregulation    fundamental    receptors    critical    consists    genes    optical    schizophrenia    orthosteric    subunit    convertible    allosteric    innovative    therapeutic    manipulation    glun2a    nmdar    reversibly    nmdars    glun1    form    stroke    nmda    roles    synapses    models    tetramers    population    counteract    temporal    spatio    containing    generally    neuronal    neurotransmitter    precise    ing    usually    retardation    subtypes    optonmda    anatomical    pathologies    synaptic    photo    lacking    genetic    pharmacological    compounds    competitive    allostery    opto    polyamine    individual    excitatory    modulating    play    glutamate    hypo    tools    act    selectively    manner    strategies    brain    function    configuration    functional    class    mammalian    circuit    isomerize    biophysical   

Project "OptoNMDA" data sheet

The following table provides information about the project.

Coordinator		 INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 

Organization address
address: RUE DE TOLBIAC 101
city: PARIS
postcode: 75654
website: www.inserm.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country France [FR]
 Project website http://www.mony.fr/optoNMDA.shtml
 Total cost 185˙076 €
 EC max contribution 185˙076 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2015
 Funding Scheme MSCA-IF-EF-RI
 Starting year 2016
 Duration (year-month-day) from 2016-04-01   to  2018-07-21

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) coordinator 115˙672.00
2    ECOLE NORMALE SUPERIEURE FR (PARIS CEDEX 05) participant 69˙403.00

Map

 Project objective

NMDA receptors (NMDARs) form a class of receptors gated by glutamate, the major neurotransmitter in the mammalian brain. These receptors play fundamental roles in synaptic transmission and plasticity. They are also involved in numerous pathologies including stroke, mental retardation or schizophrenia. NMDARs are thus targets of strong therapeutic interest. NMDARs are tetramers usually composed of two GluN1 and two GluN2 subunits encoded by four different genes (GluN2A-D), resulting in a large number of receptor subtypes having distinct anatomical, biophysical, pharmacological and signalling properties. Understanding the functional role of these individual subtypes in the brain is of great importance to develop new strategies to counteract the deleterious effects of NMDAR dysregulation. However, tools allowing targeting of a specific population of NMDARs in a given neuronal circuit are currently lacking. The OptoNMDA research programme proposes the development of an innovative optical approach to selectively enhance the activity of NMDARs containing the GluN2B subunit (GluN2B-NMDARs) in ex vivo and in vivo preparations. This approach consists in developing photo-convertible polyamine derivatives that can reversibly isomerize between an inactive and active configuration with light to act on the GluN2B-NMDAR polyamine allosteric modulating site in a precise spatio-temporal manner (opto-allostery). I will study the physiological and potential therapeutic roles of these compounds by testing their effects on synaptic transmission and plasticity and on genetic models of NMDAR hypo-function. Compared to previous studies targeting orthosteric (competitive) sites, the opto-allostery approach will allow manipulation of NMDARs in a more specific and physiological manner. This project should thus provide critical novel information on NMDARs, and more generally, on the physiology and pathology of excitatory synapses.

 Publications

year authors and title journal last update
List of publications.
2018 Viktoria Klippenstein, Laetitia Mony, Pierre Paoletti
Probing Ion Channel Structure and Function Using Light-Sensitive Amino Acids
published pages: 436-451, ISSN: 0968-0004, DOI: 10.1016/j.tibs.2018.02.012 		Trends in Biochemical Sciences 43/6 2019-07-26

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OPTONMDA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OPTONMDA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

MemoryAggregates (2020)

Mechanism of Whi3 Aggregation and its Age-dependent Malfunction

Read More  

RipGEESE (2020)

Identifying the ripples of gene regulation evolution in the evolution of gene sequences to determine when animal nervous systems evolved

Read More  

NarrowbandSSL (2019)

Development of Narrow Band Blue and Red Emitting Macromolecules for Solution-Processed Solid State Lighting Devices

Read More